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Previewsexperimental approach Sakai et al.
recently identified a protein interaction
network, functionally connecting hun-
dreds of proteins to known and novel
ASD proteins. In particular, they exempli-
fied how a protein interaction network
based on proteins primarily associated
with syndromic autism can be used to
identify causative mutations in individuals
with nonsyndromic autism (Sakai et al.,
2011). This suggests a significant overlap
in the genetics of syndromic and nonsyn-
dromic autism.
The identification of key molecular
pathways that link many ASD-causing
genes is of utmost importance when it
comes to potential therapeutic interven-
tions. It is very likely that there will be
hundreds of autism genes and proteins;
thus designing treatments for ASDs
tackling one gene at a time will be a
challenge. Identifying functional relation-
ships and interactions between various
ASD-associated proteins is likely to
identify signaling pathways and subcel-
lular compartments that encompass
a whole subgroup of such genes. Having
such rich functional pathway information808 Neuron 70, June 9, 2011 ª2011 Elseviermight unearth common targets that are
amenable to therapy.
This is a very exciting time for autism
research. Large, thoroughly phenotyped
cohorts and collections of biospecimens
are available. Many ASD loci and genes
have been identified and are just begin-
ning to be connected in functional
networks. While we are awaiting the
results of multiple large-scale sequencing
efforts, the field is poised to move on to
functional studies that will help under-
stand the molecular underpinnings and
neural substrates of this disorder in
hopes of developing more effective
interventions.REFERENCES
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Vascular endothelial growth factor (VEGF) family members are best known for their powerful mitotic and
angiogenic activities toward endothelial cells. Two independent studies in this issue of Neuron now provide
compelling evidence that VEGF-A secreted at the CNS midline functions as an attractant for developing
axons of spinal commissural neurons and contralaterally projecting retinal ganglion cells.The assembly of a highly organized
network of neuronal connections is a key
developmental process and essential for
all neural function, ranging from simple
movement to complex cognitive pro-
cesses. Research focused on the cellular
strategies and molecular mechanismsthat orchestrate neural network assembly
led to the discovery of a wide variety of
axon guidance molecules and receptors
(Kolodkin and Tessier-Lavigne, 2010).
Many guidance molecules are evolution-
arily conserved and, based on their
mode of action, are categorized intoshort- or long-range guidance cues that
influence growth cone steering in a posi-
tive (attractive) or negative (repulsive/
inhibitory) manner. We now know that
the activity of an individual guidance cue
is not absolute, but instead interpreted






































Figure 1. Axon Guidance Mechanisms at the CNS
Midline
(A) Embryonic spinal cord showing trajectory of commis-
sural axons. Precrossing spinal commissural axons are
initially pushed ventrally by roof plate-derived inhibitory
cues, including BMPs and Draxin (red gradient). Chemoat-
tractants secreted by the floor plate include Netrin-1, Shh,
and VEGF (green gradient). After crossing the midline,
commissural axons lose attraction to Netrin-1 and Shh.
Conversely, factors such as Slits, Sema3B, and Sema3F,
which have no effect on commissural axons before
crossing, become potent repellents after crossing.
(B) Invertebrateswith frontally locatedeyes, subpopulations
of RGC axons are segregated at the optic chiasm to project
to targets on both the ipsilateral and contralateral side of the
brain. EphrinB2andShhat the chiasmmidline are repellents
for EphB1- and Boc-expressing RGCs destined for the ipsi-
lateral optic tract. NrCAM expressed by RGCs is required in
a small subset of late born neurons to form contralatera
projections. The VEGF-A isoform VEGF164 is expressed
at the midline where it functions as a chemoattractant for
Npn-1-positive RGCs to instruct contralateral growth. D
dorsal; V, ventral; N, nasal; T, temporal retina.
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Previewscontext-dependent manner. Impor-
tant conceptual advances in deci-
phering the molecular language of
axon guidance and network assembly
include the discovery of hierarchies
among guidance cues, the identifica-
tion of molecular switches that when
flipped turn an attractive cue into an
inhibitory one (or vice versa), and
the existence of diverse receptor
complexes that facilitate cell-type-
specific responses to a specific guid-
ance cue. The discovery of general
principles underlying the wiring of
the developing nervous system
provides insight into the molecular
logic that allows a relatively small set
of guidance cues to initiate the
assembly of complex neural networks
with myriad interconnected circuits.
In this issue, Erskine et al. (2011) and
Ruiz de Almodovar et al. (2011) now
provide new evidence that a key
angiogenic factor, VEGF-A, exhibits
angiogenesis-independent chemoat-
tractive effects on spinal commissural
and retinal ganglion cell axons at the
CNS midline.
It is not by chance that analysis of
nervous system midline development
has been particularly successful in the
discovery of guidance cues and the
elucidation of axon pathfinding mech-
anisms. Axons extending toward the
CNS midline during development
must make an important decision: to
cross and find a synaptic partner on
the contralateral side of the nervous
system (relative to their cell body) or
not to cross and remain confined to
the ipsilateral side. Extensive work
in fruit flies, worms, fish, chicks,
and mice has established that the
midline is a rich source of chemoat-
tractants and chemorepellents
(Figure 1A) (Dickson and Zou, 2010).
Vertebrate Netrin-1 is a robust che-
moattractant for spinal commissural
axons and is secreted by floor
plate cells located at the ventral
midline. Despite its strong and long-
range attractive capabilities, Netrin-1
collaborates with several additional
cues to direct precrossing commis-
sural axons toward the floor plate.Chemorepellents, including BMPs and
Draxin, are released by the roof plate
and initially ‘‘push’’ commissural axonsventrally into an increasing Netrin-1
gradient. The floor plate also secretes
the morphogen sonic hedgehog (Shh).NeuroLike Netrin-1, Shh is a chemoattrac-
tant for precrossing commissural
axons. Once at the floor plate,
commissural axons lose their interest
in Netrin-1 and Shh and acquire
responsiveness to floor-plate-derived
repellents, including slits and sema-
phorins, allowing them to exit the floor
plate and move on to the second
leg of their journey (Dickson and
Zou, 2010). Remarkably, precrossing
spinal commissural neurons exposed
to a Netrin-1-deficient floor plate in
the presence of Shh signaling inhibi-
tors show residual attraction, indi-
cating the existence of additional,
unidentified floor plate attractant(s)
(Charron et al., 2003).
In the developing visual system,
retinal ganglion cell (RGC) axons
arriving at the chiasm face the same
challenge as precrossing axons in
the ventral spinal cord: to cross
or not to cross the midline. As
they approach the optic chiasm,
RGCs segregate into ipsilaterally and
contralaterally projecting fibers (Fig-
ure 1B). Proper crossing, or decussa-
tion, at the chiasm is essential for
organisms with prominent binocular
vision. The mouse has laterally posi-
tioned eyes and limited binocular
vision. A large population of RGC
axons cross the midline, and a rela-
tively small population does not cross
and project ipsilaterally. Seemingly
quite different molecular strategies
have evolved for proper growth cone
navigation at the optic chiasm and
spinal cord midline structures. Molec-
ular gatekeepers such as Netrin-1 and
Slits are either absent from the optic
chiasm or do not directly participate
in midline crossing of RGCs. Growth
inhibitory cues, on the other hand,
are abundant (Erskine and Herrera,
2007). These include the midline
repellent EphrinB2, an established
guidance cue at the mouse optic
chiasm. EphB1 is expressed by
ipsilaterally projecting RGCs and
EphrinB2 is necessary for the proper
formation of these projections. More
recent evidence suggests that Shh
repels ipsilateral RGC axons at the
optic chiasm via its receptor Boc (Fabre
et al., 2010). Semaphorin5A and Slits are
molecules that define the boundary of
l
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Previewsthe optic pathway but do not directly
participate in midline crossing (Erskine
and Herrera, 2007). Much less is known
about the molecular mechanisms that
promote midline crossing at the chiasm.
In zebrafish, the secreted semaphorin
Sema3D is expressed at the midline
and is thought to provide inhibitory signals
at the chiasm midline to help channel
RGC axons to the contralateral optic
tract (Sakai and Halloran, 2006). The cell
adhesion molecule NrCAM is expressed
at the mouse chiasm and also in a
small subset of late born RGCs, and it
promotes their midline crossing in vivo
(Williams et al., 2006). Cell culture ex-
periments raised the possibility that a
growth-promoting factor that mediates
RGC axon crossing at the midline is
present at the optic chiasm, suggesting
that decussation is not a default mecha-
nism but an active process involving
unknown chemoattractive cue(s) (Tian
et al., 2008).
A pair of exciting new studies (Erskine
et al. [2011] and Ruiz de Almodovar
et al. [2011]) demonstrate for the first
time that vascular endothelial growth
factor (VEGF)-A released at the CNS
midline functions as a chemoattractant
for spinal commissural and RGC axons
in vivo. Erskine et al. show that in the
mammalian visual system, VEGF func-
tions as a growth-promoting factor that
promotes extension of contralaterally pro-
jecting RGC axons across the midline,
while Ruiz de Almodovar et al. find that
in the spinal cord, VEGF secreted from
the floor plate is an attractant for pre-
crossing spinal commissural axons.
VEGF is best known for its proangiogenic
function during blood vessel growth
in vivo, and recent studies have revealed
that VEGF also promotes neural progen-
itor proliferation, survival, migration, and
differentiation (Greenberg and Jin, 2005).
However, these present studies demon-
strate the versatility of VEGF-A, expanding
its repertoire to include chemoattractant
function essential for proper nervous
system wiring.
In their search for guidance cues that
function as chemoattractants at the
mammalian optic chiasm, Erskine and
colleagues initially observe that mice
lackingNeuropilin-1 (Npn-1), a transmem-
brane receptor for class 3 Semaphorins
and select isoforms of VEGF-A (Adams810 Neuron 70, June 9, 2011 ª2011 Elsevierand Eichmann, 2010), display increased
ipsilateral projections at the optic chiasm
at embryonic day (E)14.5 in vivo. No
defects at the chiasm were observed in
mice deficient for the related Neuropilin-
2 receptor. Despite the early lethality of
Npn-1 germline null mice, the chiasm
appears to develop normally, and no
changes in expression of EphrinB2 or
Slits were observed. Furthermore, the
ventrotemporal domain of the retina that
gives rise to most ipsilateral RGC projec-
tions is not enlarged in Npn-1 mutants.
When coupled with the strong expression
of Npn-1 on contralaterally projecting
RGC axons, this phenotype suggested
a role for Npn-1 in promoting RGC axon
midline crossing. Interestingly, expres-
sion of class 3 Semaphorin family
members (Sema3s) at the chiasm is not
observed, or is extremely low, at the
time when RGCs cross. To rule out poten-
tial influences from more remote Sema3
sources, mice carrying a Npn-1 point
mutation that abolishes Sema3, but not
VEGF, signaling (Npn1Sema/) (Gu et al.,
2003) were analyzed. Similar to wild-
type mice, Npn1Sema/ mice show no
midline crossing defects at the optic
chiasm. With a vital role for Sema3s elim-
inated, Erskine et al. (2011) turned their
attention to isoforms of VEGF-A, a second
class of Npn-1 ligands. VEGF-A is
strongly expressed at the embryonic
optic chiasm in the mouse. To explore
the possibility that VEGF is the Npn-1
ligand that promotes contralateral RGC
axon growth, Erskine et al. (2011)
analyzed Vegfa120/120 mice, which cannot
produce the Npn-1-binding isoforms
VEGF164 or VEGF188, but do express
VEGF120, which does not bind Npn-1
and supports blood vessel formation.
Similar to Npn-1 null mice, Vegfa120/120
mice display increased ipsilateral pro-
jections and decreased contralateral
projections, supporting the idea that
VEGF/Npn-1 interactions promote RGC
axon crossing at the optic chiasm.
Vegfa120/120 mice survive to birth, so
retrograde DiI labeling was employed to
independently assess ipsilaterally projec-
ting RGC axons and determine the origin
of misrouted axons within the retina.
In wild-type mice, ipsilateral RGCs are
primarily restricted to the ventrotemporal
region of the retina (Figure 1B). In
Vegfa120/120 mice, however, retrogradelyInc.labeled RGCs were found throughout
the temporal and nasal retina. To directly
test whether VEGF functions as a chemo-
attractant, RGC growth cones were
exposed to a VEGF164 gradient. Consis-
tent with a previous study showing that
VEGF promotes regenerative growth of
axotomized RGCs in culture (Bo¨cker-
Meffert et al., 2002), VEGF164 was found
to act as a selective attractant for dorso-
temporal RGC growth cones, neurons
that give rise to contralateral projections,
but not for ventrotemporal RGC growth
cones, neurons that give rise to ipsilateral
projections. Collectively, these studies
show that VEGF164 functions as a che-
moattractant to promote midline crossing
of Npn-1-expressing RGC axons at the
optic chiasm in vivo.
VEGF also functions as an attractant for
spinal commissural axons, as reported in
the study by Ruiz de Almodovar et al.
(2011). VEGF is expressed at the floor
plate at the time when spinal commissural
axons cross the midline (Figure 1A). Mice
lacking function of a single VEGF allele
specifically in the floor plate (Vegf FP+/)
secrete less VEGF and exhibit concomi-
tant abnormal pathfinding of precrossing
commissural axons. While most Robo3-
positive commissural axons reach the
floor plate in Vegf FP+/ mice, labeled
commissural axons in embryonic spinal
cord sections are observed to be defasci-
culated, and they often project to the
lateral edge of the ventral spinal cord.
Important control experiments show that
the defects observed are not secondary
to altered expression of Netrin-1 or Shh
in the floor plate of Vegf FP+/ mice.
In vitro, an attractive response by com-
missural axons to a gradient of VEGF-A
was observed in the Dunn chamber
assay. Interestingly, VEGF-A attraction
was completely abolished in the presence
of a function blocking anti-Flk1 (KDR/
VEGFR2) antibody or by pharmacological
inhibition of Src family kinases. Anti-Npn1
in this same assay had no effect
on VEGF-A attraction. Immunolabeling
of precrossing commissural axons re-
vealed coexpression of Flk1 and Robo3,
and in vivo, conditional ablation of
Flk1 in commissural neurons (Flk1CN-ko)
phenocopies defects observed in the
Vegf FP+/mice. The patterns and expres-
sion levels of Netrin-1 and Shh in the floor
plate in Flk1CN-ko mice are comparable to
Neuron
Previewswild-type littermates, indicating that Flk1
cell-autonomously controls VEGF-medi-
ated attraction of precrossing commis-
sural axons in vivo.
Taken together, these studies are the
first to report that VEGF is essential for
proper axon guidance at the CNS midline
in vivo. VEGF-A functions as a midline-
derived chemoattractant for RGC axons
in the diencephalon and functions simi-
larly for commissural axons in the devel-
oping spinal cord. In the visual system,
Npn-1 is an obligatory receptor for VEGF
attraction, while in the developing spinal
cord, Flk1 is required for the VEGF-medi-
ated attractive response. No significant
expression of Flk1 or Flt1 is detected in
developing RGCs (Erskine et al., 2011),
and conversely, Npn-1 is not expressed
by precrossing spinal commissural
neurons (Ruiz de Almodovar et al.,
2011). Although, Flk1 mutants have not
been examined for RGC midline crossing
defects, the current data suggest that
RGCs and spinal commissural neurons
employ distinct and independent sig-
naling mechanisms for VEGF attraction.
How does VEGF signal attraction in
RGCs? Npn-1 is a type-1 transmembrane
protein with a short cytoplasmic domain,
and one possibility is that Npn-1 signals
attraction through its cytoplasmicdomain,
independent of a coreceptor(s). Alterna-
tively, Npn-1 might form a complex with
a coreceptor to form a holoreceptor
complex that signals VEGF attraction.
NrCAM has been shown to regulate neu-
ropilin signaling in response to Sema3s
during commissural axon guidance in the
anterior commissure (Falk et al., 2005).
When coupled with NrCAM’s role in
promoting RGC axon midline crossing
in vivo, it is possible that NrCAM is part
of a Npn-1/VEGF receptor complex which
promotes midline crossing. Arguing
against this possibility, however, are the
distinct temporal requirements for NrCAM
and Npn-1/VEGF for proper decussation
of RGC axons. Defective RGC midline
crossing in Npn-1and Vegfa120/120mutant
mice is observed as early as E14, while
defects in NrCAM mutants are observed
only late in visual system development,
from E17.5 onward (Williams et al., 2006).
Recent evidence suggests that Flk1 func-
tions as the signal transducing receptor
component for Sema3E, providing addi-
tional evidence for shared mechanismsinvolving Sema3s and VEGF (Bellon
et al., 2010). These present studies do
not address whether VEGF influences
guidance in a Plexin-dependent manner.
Npn-1 forms a complex with Plexin recep-
tors, and Plexins are regulators of both
attractive and repulsive axon guidance
(Kolodkin and Tessier-Lavigne, 2010).
Genetic tools are available, and it will be
interesting to examine whether Plexin
mutants show guidance defects at the
CNS midline related to impaired VEGF
function.
The identification of VEGF as a novel
midline attractant released by the floor
plate begs the question as to how VEGF
might fit in with previously identified spinal
commissural axon guidance mecha-
nisms. For precrossing, Flk1-positive
axons, VEGF released by the floor plate
presumably collaborates with Netrin-1
and Shh in commissural axon attraction.
While most Robo3-positive axons reach
the floor plate in Vegf FP+/ mice, some
of these axons stall and are misrouted
into a more lateral trajectory. The most
noticeable phenotype in Vegf FP+/ mice
is axon defasciulation. Defects observed
in Vegf FP+/ mice are similar to those
observed in mice deficient for the Shh
receptor Boc and the Shh signaling
component Smoothened (Charron et al.,
2003; Okada et al., 2006). However, these
phenotypes are less pronounced than the
Netrin-1 phenotype, since the majority of
precrossing commissural axons are able
to reach the midline. In Netrin-1 mutants
on the other hand, most precrossing
commissural axons stall and fail to enter
the ventral spinal cord. This suggests
that in the absence of Netrin-1, the ventral
spinal cord may be nonpermissive for
commissural axon growth. Thus, Shh and
VEGF may function primarily in commis-
sural axon attraction, while Netrin-1 is im-
portant for outgrowth and attraction.
Consistent with this idea, Shh and VEGF
attract precrossing commissural axons,
but exhibit no growth promoting effects
in vitro (Charron et al., 2003; Ruiz de
Almodovar et al., 2011).
Next on the agenda will be questions
concerning how commissural axons
cope with VEGF attraction after they
have entered the floor plate. Are there
mechanisms in place that modulate, or
silence, VEGF attraction, similar to those
reported for Netrin-1 and Shh? Alterna-Neurotively, is loss of Netrin-1 attraction, in
conjugation with acquisition of Slit and
Sema3 inhibition, sufficient to prevent
postcrossing commissural axons from
recrossing the midline as they travel
rostrally, despite continuing VEGF attrac-
tion? Ultimately, a detailed understanding
of growth cone navigation at the midline
requires a combination of tools that allow
temporal and spatial regulation of guid-
ance cues, their receptors, and down-
stream effectors. When combined with
live imaging of commissural axon
subpopulations, this approach will reveal
insights into the contributions of individual
cues as they promote proper axon navi-
gation at the CNS midline. The identifica-
tion of VEGF as a midline attractant by
Erskine et al. (2011) and Ruiz de Almodo-
var et al. (2011) represents an important
advance toward this goal.REFERENCES
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